ENDRA Life Sciences Inc. (NDRA)

Market Cap	2.96M
Revenue (ttm)	n/a
Net Income (ttm)	-8.82M
Shares Out	536.91K
EPS (ttm)	-128.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,751
Open	5.29
Previous Close	5.37
Day's Range	5.17 - 6.30
52-Week Range	4.01 - 4,663.75
Beta	0.56
Analysts	Strong Buy
Price Target	14,000.00 (+253,983.49%)
Earnings Date	Nov 15, 2024

About NDRA

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was in...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2017
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: NDRA
• Website: https://endrainc.com

Analyst Forecast

According to one analyst, the rating for NDRA stock is "Strong Buy" and the 12-month stock price forecast is $14,000.0.

Price Target

$14,000.0

(253,983.49% upside)

Analyst Consensus: Strong Buy